1. Home
  2. LOVE vs ELTX Comparison

LOVE vs ELTX Comparison

Compare LOVE & ELTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo The Lovesac Company

LOVE

The Lovesac Company

HOLD

Current Price

$16.00

Market Cap

193.2M

ML Signal

HOLD

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$9.91

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOVE
ELTX
Founded
1998
2011
Country
United States
United States
Employees
N/A
33
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
193.2M
185.4M
IPO Year
2018
2014

Fundamental Metrics

Financial Performance
Metric
LOVE
ELTX
Price
$16.00
$9.91
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
3
Target Price
$25.00
$18.00
AVG Volume (30 Days)
231.8K
112.2K
Earning Date
06-11-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
39.29
EPS
0.28
N/A
Revenue
$697,115,000.00
$2,301,000.00
Revenue This Year
$4.63
N/A
Revenue Next Year
$6.40
N/A
P/E Ratio
$55.43
N/A
Revenue Growth
2.42
N/A
52 Week Low
$10.33
$5.80
52 Week High
$21.90
$14.93

Technical Indicators

Market Signals
Indicator
LOVE
ELTX
Relative Strength Index (RSI) 55.86 38.27
Support Level $14.04 $8.76
Resistance Level $16.33 $10.16
Average True Range (ATR) 0.67 0.75
MACD -0.20 -0.19
Stochastic Oscillator 27.27 2.14

Price Performance

Historical Comparison
LOVE
ELTX

About LOVE The Lovesac Company

The Lovesac Co designs, manufactures and sells alternative furniture which is comprised of modular couches called sactionals and premium foam beanbag chairs called sacs. It also offers other accessories such as sactional-specific drink holders, Footsac blankets, decorative pillows, fitted seat tables, and ottomans. Its products are sold across the United States through its website or company-owned retail stores which are used in homes and offices. The majority of the firm's revenue is derived from the sale of Sactionals.

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Share on Social Networks: